Ulthera wins a new U.S. patent for non-invasive sweat reduction treatment, which expands the intellectual property portfolio for the Ulthera System Platform.
Aesthetic devices maker Ulthera won a new U.S. patent for an ultrasound-based therapy for treating sweat glands disorders, such as hyperhidrosis
The patent, titled "Methods for treatment of sweat glands" was granted by the U.S. Patent & Trademark Office late last week, according to a press release.
"This new patent adds a significant asset to the patent portfolio for Ulthera, which has rights to over 100 U.S. and international patents that are issued, published or pending," president & CEO Matthew Likens said in prepared remarks. "The groundbreaking advances underlying this patent are a result of many years of collaboration between Ulthera and Guided Therapy Systems, LLC, a global innovator of ultrasound-based technology."